Pfizer Seeking Inversions Shows Companies Unfazed by Treasury Department

Pfizer has approached Actavis about a deal that could allow the U.S. drugmaker to move its address overseas and reduce taxes, in a sign the Obama administration’s efforts to curtail inversions might fall short.
Bloomberg